agilon health (NYSE:AGL) Shares Down 6.2% – Should You Sell?

agilon health, inc. (NYSE:AGL)’s share price fell 6.2% during mid-day trading on Monday . The company traded as low as $3.00 and last traded at $3.01. 659,405 shares changed hands during trading, a decline of 87% from the average session volume of 4,990,672 shares. The stock had previously closed at $3.21.

Analyst Upgrades and Downgrades

AGL has been the subject of a number of research analyst reports. Benchmark reiterated a “buy” rating and issued a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft cut their price target on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Evercore ISI decreased their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $8.03.

agilon health Stock Down 1.1 %

The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The firm has a 50-day moving average of $4.33 and a 200 day moving average of $5.35. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -4.50 and a beta of 0.54.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.07). The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business’s revenue was up 38.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.04) EPS. As a group, sell-side analysts forecast that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On agilon health

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after acquiring an additional 371,537 shares during the period. AQR Capital Management LLC increased its stake in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock worth $127,256,000 after purchasing an additional 3,195,087 shares during the last quarter. Susquehanna Fundamental Investments LLC lifted its holdings in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Finally, Capital International Investors boosted its stake in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.